ImmunityBio (IBRX) Share-based Compensation (2014 - 2026)
ImmunityBio (IBRX) recorded Share-based Compensation of $8.52 million in Q2 2026, down 11.7% from $9.65 million a year earlier but up 4.3% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Share-based Compensation (2014 - 2026) Analysis & Trends
On a TTM basis, ImmunityBio's Share-based Compensation came in at $34.31 million as of Jun 30, 2026, down 3.9% year-over-year; for FY2025, it was $36.81 million, up 6.9% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of 75.9% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $34.43 million in FY2024 (-30.0%), $49.16 million in FY2023 (+22.4%), $40.18 million in FY2022 (-29.7%) and $57.18 million in FY2021.
- Quarterly Share-based Compensation has ranged from $7.49 million in Q3 2024 to $14.45 million in Q3 2023 over the past five years.
- On a year-over-year basis, Share-based Compensation has declined for three consecutive quarters, with an average decline of 9.1% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 36.6% in Q4 2023, against a decline of 48.2% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $8.17 million (Q1 2026), $8.75 million (Q4 2025) and $8.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | ImmunityBio | 8.97 Bn | 7.74 Bn | 50.94 Mn | 8.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.52 Mn |
| Mar 31, 2026 | 8.17 Mn |
| Dec 31, 2025 | 8.75 Mn |
| Sep 30, 2025 | 8.88 Mn |
| Jun 30, 2025 | 9.65 Mn |
| Mar 31, 2025 | 9.54 Mn |
| Dec 31, 2024 | 9.04 Mn |
| Sep 30, 2024 | 7.49 Mn |
| Jun 30, 2024 | 9.64 Mn |
| Mar 31, 2024 | 8.27 Mn |
| Dec 31, 2023 | 12.77 Mn |
| Sep 30, 2023 | 14.45 Mn |
| Jun 30, 2023 | 11.06 Mn |
| Mar 31, 2023 | 10.88 Mn |
| Dec 31, 2022 | 9.35 Mn |
| Sep 30, 2022 | 10.63 Mn |
| Jun 30, 2022 | 10.18 Mn |
| Mar 31, 2022 | 10.02 Mn |
| Dec 31, 2021 | 10.18 Mn |
| Sep 30, 2021 | 13.84 Mn |
API Access
ImmunityBio Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();